## Neurochemical Basis of Major Depressive Disorder **Key Point:** The monoamine hypothesis, particularly serotonin deficiency, is the most widely accepted neurochemical model of Major Depressive Disorder and forms the basis of first-line pharmacological treatment. ### The Monoamine Hypothesis The classical understanding of MDD involves dysfunction of three monoamine neurotransmitter systems: | Neurotransmitter | Role in MDD | Clinical Correlate | |---|---|---| | **Serotonin** | Most common deficiency; regulates mood, sleep, appetite | Core depressive symptoms | | **Norepinephrine** | Deficiency contributes to anhedonia and fatigue | Loss of motivation and energy | | **Dopamine** | Deficiency linked to anhedonia and psychomotor retardation | Loss of pleasure and motivation | **High-Yield:** Serotonin dysfunction is the **most frequently cited and most common** neurochemical abnormality in MDD. This is why selective serotonin reuptake inhibitors (SSRIs) are the first-line pharmacological agents. ### Evidence for Serotonin Deficiency 1. **Tryptophan depletion studies** — acute reduction of serotonin precursor worsens mood in vulnerable individuals 2. **Cerebrospinal fluid (CSF) studies** — reduced 5-hydroxyindoleacetic acid (5-HIAA), a serotonin metabolite, in depressed patients 3. **Receptor binding studies** — abnormalities in serotonin transporter (SERT) and 5-HT receptors 4. **SSRI efficacy** — SSRIs block serotonin reuptake and are the most effective and tolerated first-line agents **Clinical Pearl:** While serotonin is the most common dysfunction, MDD is increasingly recognized as a disorder of **multiple neurotransmitter systems** and neural circuits (prefrontal cortex, amygdala, hippocampus, anterior cingulate). However, for examination purposes, serotonin deficiency remains the "most common" answer. **Mnemonic: SAD MONOAMINES** — Serotonin, Acetylcholine Deficiency; Monoamine Oxidase, Norepinephrine, Dopamine, Acetylcholine, Melatonin, Imbalance, Norepinephrine, Endocrine, Serotonin (captures the key neurotransmitters involved). ### Why Other Options Are Less Common - **Dopamine excess** — Dopamine is typically **deficient** (not in excess) in MDD; dopamine agonists may help anhedonia but are not first-line. - **Acetylcholine deficiency** — While anticholinergic effects can worsen mood, primary acetylcholine dysfunction is not a major mechanism in MDD. - **Glutamate excess** — Emerging research suggests glutamate dysregulation, but this is a **secondary or supplementary** mechanism, not the most common primary abnormality.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.